庆祝MMC六年的经验和壮大 von Raz, Itamar

Volltext

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trial... von Zelniker, Thomas A, Wiviott, Stephen D, Raz, Itamar, Im, Kyungah, Goodrich, Erica L, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Furtado, Remo H M, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P H, Sabatine, Marc S

Volltext

Prediction of progression from pre‐diabetes to diabetes: Development and validation of a machine learning model von Cahn, Avivit, Shoshan, Avi, Sagiv, Tal, Yesharim, Rachel, Goshen, Ran, Shalev, Varda, Raz, Itamar

Volltext

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus von Kato, Eri T, Silverman, Michael G, Mosenzon, Ofri, Zelniker, Thomas A, Cahn, Avivit, Furtado, Remo H.M, Kuder, Julia, Murphy, Sabina A, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P.H, Bonaca, Marc P, Ruff, Christian T, Desai, Akshay S, Goto, Shinya, Johansson, Peter A, Gause-Nilsson, Ingrid, Johanson, Per, Langkilde, Anna Maria, Raz, Itamar, Sabatine, Marc S, Wiviott, Stephen D

Volltext

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial von Mosenzon, Ofri, Leibowitz, Gil, Bhatt, Deepak L, Cahn, Avivit, Hirshberg, Boaz, Wei, Cheryl, Im, KyungAh, Rozenberg, Aliza, Yanuv, Ilan, Stahre, Christina, Ray, Kausik K, Iqbal, Nayyar, Braunwald, Eugene, Scirica, Benjamin M, Raz, Itamar

Volltext

Therapy in the Early Stage: Incretins von Cernea, Simona, Raz, Itamar

Volltext

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial von SCIRICA, Benjamin M, BRAUNWALD, Eugene, POLLACK, Pia S, HIRSHBERG, Boaz, FREDERICH, Robert, LEWIS, Basil S, MCGUIRE, Darren K, DAVIDSON, Jaime, STEG, Gabriel, BHATT, Deepak L, RAZ, Itamar, CAVENDER, Matthew A, MORROW, David A, JAROLIM, Petr, UDELL, Jacob A, MOSENZON, Ofri, KYUNGAH IM, UMEZ-ERONINI, Amarachi A

Volltext

Patient clusters based on HbA1c trajectories: A step toward individualized medicine in type 2 diabetes von Karpati, Tomas, Leventer-Roberts, Maya, Feldman, Becca, Cohen-Stavi, Chandra, Raz, Itamar, Balicer, Ran

Volltext

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study von Cahn, Avivit, Mosenzon, Ofri, Wiviott, Stephen D, Rozenberg, Aliza, Yanuv, Ilan, Goodrich, Erica L, Murphy, Sabina A, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P H, Gause-Nilsson, Ingrid A M, Fredriksson, Martin, Johansson, Peter A, Langkilde, Anna Maria, Sabatine, Marc S, Raz, Itamar

Volltext

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum von Cefalu, William T, Buse, John B, Tuomilehto, Jaakko, Fleming, G Alexander, Ferrannini, Ele, Gerstein, Hertzel C, Bennett, Peter H, Ramachandran, Ambady, Raz, Itamar, Rosenstock, Julio, Kahn, Steven E

Volltext

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial von Wiviott, Stephen D., Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A., McGuire, Darren K., Wilding, John PH, Gause-Nilsson, Ingrid AM, Langkilde, Anna Maria, Johansson, Peter A., Sabatine, Marc S.

Volltext

Overview of oxidative stress and inflammation in diabetes von Weinberg Sibony, Roni, Segev, Omri, Dor, Saar, Raz, Itamar

Volltext

Early Insulinization to Prevent Diabetes Progression von RAZ, Itamar, MOSENZON, Ofri

Volltext

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58 von Mosenzon, Ofri, Wiviott, Stephen D., Heerspink, Hiddo J.L., Dwyer, Jamie P., Cahn, Avivit, Goodrich, Erica L., Rozenberg, Aliza, Schechter, Meir, Yanuv, Ilan, Murphy, Sabina A., Zelniker, Thomas A., Gause-Nilsson, Ingrid A.M., Langkilde, Anna Maria, Fredriksson, Martin, Johansson, Peter A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Sabatine, Marc S., Raz, Itamar

Volltext

From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes von Mosenzon, Ofri, Del Prato, Stefano, Schechter, Meir, Leiter, Lawrence A, Ceriello, Antonio, DeFronzo, Ralph A, Raz, Itamar

Volltext

DECLARE‐TIMI 58: Participants’ baseline characteristics von Raz, Itamar, Mosenzon, Ofri, Bonaca, Marc P., Cahn, Avivit, Kato, Eri T., Silverman, Michael G., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P. H., Gause‐Nilsson, Ingrid A. M., Langkilde, Anna M., Johansson, Peter A., Sabatine, Marc S., Wiviott, Stephen D.

Volltext

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy von Ziegler, Dan, Ametov, Alexander, Barinov, Alexey, Dyck, Peter J., Gurieva, Irina, Low, Phillip A., Munzel, Ullrich, Yakhno, Nikolai, Raz, Itamar, Novosadova, Maria, Maus, Joachim, Samigullin, Rustem

Volltext

Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women von Auryan, Szalat, Itamar, Raz

Volltext

Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial) von Aoki, Yasunori, Hamrén, Bengt, Clegg, Lindsay E, Stahre, Christina, Bhatt, Deepak L, Raz, Itamar, Scirica, Benjamin M, Oscarsson, Jan, Carlsson, Björn

Volltext

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c von Cavender, Matthew A., MD, MPH, Scirica, Benjamin M., MD, MPH, Raz, Itamar, MD, Gabriel Steg, Ph., MD, McGuire, Darren K., MD, MHSc, Leiter, Lawrence A., MD, Hirshberg, Boaz, MD, Davidson, Jaime, MD, Cahn, Avivit, MD, Mosenzon, Ofri, MD, Im, KyungAh, PhD, Braunwald, Eugene, MD, Bhatt, Deepak L., MD, MPH

Volltext